[Federal Register Volume 78, Number 245 (Friday, December 20, 2013)]
[Notices]
[Page 77107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-30357]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning Therapeutic 
Peptides That Inhibit Rift Valley Fever Virus, Ebola Virus, Andes Virus 
and Vesicular Stomatitis Virus Infectivity, Compositions and Methods

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/733,966, entitled ``Therapeutic Peptides that Inhibit Rift Valley 
Fever Virus, Ebola Virus, Andes Virus and Vesicular Stomatitis Virus 
Infectivity, Compositions and Methods,'' filed on December 6, 2012. The 
United States Government, as represented by the Secretary of the Army, 
has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to novel, broad 
spectrum, antiviral peptides, compositions containing one or more of 
these and their use for the prophylactic treatment against and/or 
therapeutic treatment of infection by hemorrhagic fever viruses (HFVs), 
such as Rift Valley fever virus (RVFV), Ebola virus (EBOV), and Andes 
virus (ANDV). Additionally, these peptides were capable of inhibiting 
vesticular stomatitis virus (VSV), and agricultural pathogen with 
limited therapeutic availability.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2013-30357 Filed 12-19-13; 8:45 am]
BILLING CODE 3710-08-P